Neogen Corporation NEOG
At closeNov 3, 2026, 4:00 PM EST
After hours · Nov 3, 4:00 PM ET
- YTD
- +73.10%
- 1 year
- +92.37%
- Market cap
- 2.64B
- Revenue (ttm)
- 884.00M
- Profit margin
- -6.35%
- EPS (ttm)
- -0.26
- Shares out
- 218.31M
- Forward P/E
- 26.89
- YTD return
- +73.10%
- 1-year return
- +92.37%
- Volume
- 2.33M
- Avg volume
- 3.29M
- Open
- 11.91
- Previous close
- 11.82
- Day's range
- 11.84 – 12.15
- 52-week range
- 5.37 – 14.26
- Beta
- 1.86
- Price target
- 14.00 (+15.7%)
- Earnings date
- Jan 14, 2027
3M +0.29 (+2.46%)
Key statistics
- Enterprise value
- 3.18B
- PEG ratio
- 0.66
- Price / sales
- 2.99
- Price / book
- 1.27
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 6.50%
- Free cash flow
- 38.94M
- Total cash
- 172.00M
- Total debt
- 774.30M
- Return on equity
- -2.67%
- Short % of float
- 7.30%
- 50-day average
- 12.22
- 200-day average
- 10.43
Analyst view
- Strong buy2
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Jan 14, 2027
Expected Jan 14, 2027. Consensus EPS estimate 0.06333.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 14, 2027 | Nov 30, 2026 | 0.07 | — | — | — |
| Oct 6, 2026 | Aug 31, 2026 | 0.05333 | 0.08 | +0.03 | +50.01% |
| Jul 30, 2026 | May 31, 2026 | 0.05667 | 0.09 | +0.03 | +58.81% |
| Apr 9, 2026 | Feb 28, 2026 | 0.04 | 0.09 | +0.05 | +125.00% |
| Jan 8, 2026 | Nov 30, 2025 | 0.07 | 0.10 | +0.03 | +42.86% |
| Oct 9, 2025 | Aug 31, 2025 | -0.074 | 0.04 | +0.11 | +154.05% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 2026 | Guggenheim | main | Buy | Buy |
| Aug 26, 2026 | Piper Sandler | up | Neutral | Overweight |
| Aug 3, 2026 | Piper Sandler | reit | Neutral | Neutral |
| Jan 12, 2026 | Piper Sandler | reit | Neutral | Neutral |
| Jan 9, 2026 | Guggenheim | main | Buy | Buy |
| Dec 10, 2025 | CJS Securities | up | Market Perform | Market Outperform |
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- neogen.com
News
Neogen® To Participate in 2026 UBS Global Healthcare Conference
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
Neogen Corporation (NEOG) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Your note
Sign in to keep a note on NEOG — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADENT JOHN EDWARD | Former | Conversion of Exercise of derivative security | Oct 26, 2025 | 363,081 |
| BOEHM WILLIAM T | Director | Conversion of Exercise of derivative security | Oct 26, 2025 | 47,913 |
| BOREL JAMES C. | Director | Conversion of Exercise of derivative security | Oct 26, 2025 | 94,570 |
| JONES DOUGLAS EDWARD | Former | Conversion of Exercise of derivative security | Oct 26, 2025 | 100,881 |
| NAEMURA DAVID HARTMAN | Former | Conversion of Exercise of derivative security | Nov 30, 2025 | 90,388 |
| NASSIF MIKHEAL | Chief Executive Officer | Stock Award(Grant) | Aug 13, 2026 | 141,631 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.31% | 33,431,015 | 404.52M | Jun 29, 2026 |
| Neuberger Berman Group, LLC | 7.59% | 16,570,795 | 200.51M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.97% | 13,038,732 | 157.77M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 4.50% | 9,828,174 | 118.92M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.42% | 9,655,248 | 116.83M | Jun 29, 2026 |
| SG Americas Securities, LLC | 4.28% | 9,352,065 | 113.16M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 12,983,088 | 157.10M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 6,928,358 | 83.83M | Jun 29, 2026 |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund | 3.13% | 6,842,464 | 82.79M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.63% | 5,738,526 | 69.44M | Sep 29, 2026 |
| BARON INVESTMENT Fd.S TRT -Baron Small Cap Fd. | 2.29% | 5,000,000 | 60.50M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.28% | 4,987,158 | 60.34M | Jun 29, 2026 |
